BridgeBio Pharma, Inc. (BBIO)
77.99
+1.19
(+1.55%)
USD |
NASDAQ |
Nov 18, 16:00
77.99
0.00 (0.00%)
After-Hours: 19:29
BridgeBio Pharma Total Return Level : 76.80 for Nov. 17, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| November 17, 2026 | 76.80 |
| November 16, 2026 | 77.36 |
| November 13, 2026 | 78.30 |
| November 12, 2026 | 78.17 |
| November 11, 2026 | 79.54 |
| November 10, 2026 | 78.67 |
| November 09, 2026 | 77.93 |
| November 06, 2026 | 74.29 |
| November 05, 2026 | 74.27 |
| November 04, 2026 | 77.89 |
| November 03, 2026 | 74.03 |
| November 02, 2026 | 75.00 |
| October 30, 2026 | 74.95 |
| October 29, 2026 | 70.73 |
| October 28, 2026 | 70.82 |
| October 27, 2026 | 69.37 |
| October 26, 2026 | 68.15 |
| October 23, 2026 | 68.56 |
| October 22, 2026 | 68.12 |
| October 21, 2026 | 67.74 |
| October 20, 2026 | 67.55 |
| October 19, 2026 | 67.94 |
| October 16, 2026 | 66.39 |
| October 15, 2026 | 67.13 |
| October 14, 2026 | 64.94 |
| Date | Value |
|---|---|
| October 13, 2026 | 63.30 |
| October 12, 2026 | 65.75 |
| October 09, 2026 | 65.35 |
| October 08, 2026 | 65.04 |
| October 07, 2026 | 66.50 |
| October 06, 2026 | 66.96 |
| October 05, 2026 | 66.14 |
| October 02, 2026 | 67.25 |
| October 01, 2026 | 66.91 |
| September 30, 2026 | 65.80 |
| September 29, 2026 | 65.97 |
| September 28, 2026 | 66.61 |
| September 25, 2026 | 65.57 |
| September 24, 2026 | 66.28 |
| September 23, 2026 | 65.71 |
| September 22, 2026 | 69.23 |
| September 21, 2026 | 66.58 |
| September 18, 2026 | 66.61 |
| September 17, 2026 | 67.31 |
| September 16, 2026 | 68.30 |
| September 15, 2026 | 68.39 |
| September 14, 2026 | 72.38 |
| September 11, 2026 | 72.44 |
| September 10, 2026 | 72.50 |
| September 09, 2026 | 76.08 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Alnylam Pharmaceuticals, Inc. | 156.50 |
| Ionis Pharmaceuticals, Inc. | 26.96 |
| Cytokinetics, Inc. | 51.65 |
| Pfizer Inc. | 96.62 |
| Ultragenyx Pharmaceutical, Inc. | 16.70 |